Non-Covalent DNA-Binding Ruthenium Anticancer Drugs

Total Page:16

File Type:pdf, Size:1020Kb

Non-Covalent DNA-Binding Ruthenium Anticancer Drugs Non-Covalent DNA-Binding Ruthenium Anticancer Drugs Anna Łęczkowska A thesis submitted to the University of Birmingham for the degree of Doctor of Philosophy School of Chemistry College of Engineering and Physical Sciences The University of Birmingham June 2011 I University of Birmingham Research Archive e-theses repository This unpublished thesis/dissertation is copyright of the author and/or third parties. The intellectual property rights of the author or third parties in respect of this work are as defined by The Copyright Designs and Patents Act 1988 or as modified by any successor legislation. Any use made of information contained in this thesis/dissertation must be in accordance with that legislation and must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the permission of the copyright holder. ACKNOWLEDGMENTS I would like to express my deep gratitude to all the people who provided me with their help and support during my PhD. I would like to acknowledge Prof. Mike Hannon for having me in his group and giving me many great opportunities to participate in a number of conferences and scientific events. Prof. Kevin Chipman, Dr. Chris Bunce and Dr. Nik Hodges and their groups and all those with whom I shared time in Biosciences laboratories are very gratefully acknowledged, especially Dr. Farhat Khanim for giving me much useful advice for cell tests and biological studies. Many thanks are also due to Dr. Louise Male who solved the crystal structures of my compounds, Dr. Neil Spencer for his help with NMR experiments and Peter Ashton for mass spectrometry. The work presented in this thesis was financially supported by the European Union (Marie Curie Fellowship, COST D39) and the University of Birmingham and to these institutions I would like to express my gratitude for the generous funding I obtained. Finally, I would like to thank to my family and friends. Without your love and support I would not be even half way through this journey. In particular, I am grateful to Jean-Louis. Thank you for everything you have done for me. II TABLE OF CONTENTS ABBREVIATIONS ……………………………………………………………….. vi ABSTRACT……..………………………………………………………………... x 1. Introduction 2 1.1 DNA structure and properties……………………………………………… 3 1.1.1 B-DNA structure…………………………………………………………. 3 1.2 Metallo-anticancer drugs………………………………………………….... 5 1.2.1 Cisplatin and its derivatives…………………………………………….. 6 1.2.2 Non-platinum antitumor agents………………………………………… 10 1.2.3 Ruthenium anticancer drugs……………………………………………. 10 1.3 Supramolecular DNA-binding anticancer drugs…………………….……. 15 1.3.1 Thermodynamics of drug-DNA interactions………………………...… 16 1.3.2 Metallointercalators and metalloinsertors…………………………….. 20 1.3.3 Binding to sugar phosphate backbone……………………………....... 27 1.3.4 Beyond the canonical right-handed double helix…………………….. 28 1.3.4.1 DNA junction structures recognition…………………………………. 29 1.3.4.2 G-quadruplex DNA recognition………………………………………. 30 1.4 Aim and outline of this thesis………………………………………………. 34 1.5 References…………………………………………………………………… 35 i 2. Dinuclear Ru(II) Triple-Stranded Helicates, Synthesis, DNA Binding 46 and Cytotoxic Activities 2.1 Introduction to supramolecular cylinders…………………………………. 47 2.2 Results and discussion……………………………………………………... 51 2.2.1 Synthesis of [Ru2L3]Cl4……………………………………………….... 51 2.2.2 Towards a library of ruthenium triple-stranded helicates………….... 55 o 2.2.3 Synthesis and characterisation of [Ru2L 3]Cl4…………………...…... 55 2-im 2.2.4 Synthesis and characterisation of [Ru2L 3]Cl4…………………….. 59 4(5)-im 2.2.5 Synthesis and characterisation of [Ru2L 3]Cl4…………………... 63 2.3 DNA binding studies………………………………………………………… 65 2.3.1 Circular dichroism………………………………………………………. 66 2.3.2 Linear dichroism……………………………………………………..….. 70 2.3.3 Agarose gel mobility shift assay………………………………………. 74 2.4 Cell viability assay…………………………………………………………… 77 2.5 General discussion, conclusions and further work………………………. 79 2.6 References…………………………………………………………………… 81 3. Optical Isomers of Ru(II) Triple-Stranded Helicate 84 3.1 Introduction…………………………………………………………………... 85 3.2 Results and discussion……………………………………………………... 88 3.2.1 Enantiomer separation…………………………………………………. 88 3.2.2 X-ray structure…………………………………………………………... 91 3.3 DNA binding studies……………………..………………………………….. 92 3.3.1 Flow linear dichroism spectroscopy…………………………………... 92 ii 3.3.2 Fluorescence response……………………………………………...…. 95 3.3.3 Agarose gel mobility shift assay………………………………………. 98 3.4 General discussion, conclusions and further work………………………. 100 3.5 References…………………………………………………………………… 104 4. The Enantiodifferentiation of Chiral Ruthenium(II) Triple-Stranded 106 Helicates by Δ-TRISPHAT 4.1 Introduction…………………………………………………………………... 107 4.2 Results and discussion……………………………………………………... 110 4.3 General discussion, conclusions and further work………………………. 115 4.4 References…………………………………………………………………… 118 5. Synthesis, Characterisation and DNA Binding Studies of Ru(II) 120 Complexes with Ammine and Azopyridyl Building Units 5.1 Introduction…………………………………………………………………... 121 5.2 Results and discussion……………………………………………………... 125 5.2.1 Synthesis……………………………………….................................... 125 a 5.2.1.1 Synthesis and characterisation of [Ru2L (NH3)8]Cl4………………. 125 a 5.2.1.2 Synthesis and characterisation of [RuL (NH3)4]Cl2……………...... 129 azpy 5.2.1.3 Synthesis and characterisation of [RuL (NH3)4]Cl2……………. 131 5.2.2 Interaction with DNA……………………………………………………. 134 5.2.2.1 Absorption spectral studies………………………………………….. 135 5.2.2.2 Circular dichroism…………………………………………………….. 136 5.2.2.3 Flow linear dichroism…………………………………………………. 137 iii 5.2.2.4 DNA thermal denaturation…………………………………………… 139 5.2.2.5 Agarose gel electrophoretic mobility shift assay………………….. 141 5.2.3 Cell tests…………………………………………………………………. 141 5.3 General discussion, conclusions and further work………………………. 142 5.4 References…………………………………………………………………… 143 6. Experimental 145 6.1 General……………………………………………………………………….. 146 6.2 Synthesis……………………………………………………………………... 146 6.2.1 Synthesis of cis-[Ru(DMSO)4Cl2]……………………………………… 146 6.2.2 Synthesis of L…………………………………………………………… 147 6.2.3 Synthesis of [Ru2L3]Cl4…………………………………………………. 148 6.2.3.1 Separation of optical isomers of [Ru2L3]Cl4………………………... 150 o 6.2.4 Synthesis of L .................................................................................. 151 o 6.2.5 Synthesis of [Ru2L 3]Cl4………………………………………………... 152 2-im 6.2.6 Synthesis of L .............................................................................. 154 2-im 6.2.7 Synthesis of [Ru2L 3]Cl4……………………………………………… 155 4(5)-im 6.2.8 Synthesis of L ............................................................................ 156 4(5)-im 6.2.9 Synthesis of [Ru2L 3]Cl4…………………………………………… 157 ox 6.2.10 Synthesis of L ………………………………………………………... 158 1 6.2.11 Synthesis of L ................................................................................ 159 2 6.2.12 Synthesis of L ………………………………………………………... 160 a 6.2.13 Synthesis of L …………………………………………………………. 161 a 6.2.14 Synthesis of [Ru2L (NH3)8]Cl4………………………………………... 162 iv a 6.2.15 Synthesis of [RuL (NH3)4]Cl2…………………………………………. 163 azpy 6.2.16 Synthesis of (E)-2-(phenyldiazenyl)pyridine, L …………………. 164 azpy 6.2.17 Synthesis of [RuL (NH3)4]Cl2……………………………………… 165 6.3 DNA binding studies………………………………………………………… 167 6.3.1 Materials and methods……………………………………………….… 167 6.3.2 Circular and linear dichroism…………………………………………... 168 6.3.3 Agarose gel experiments………………………………………………. 169 6.3.4 Thermal denaturation…………………………………………………… 169 6.4 Cell tests……………………………………………………………………… 170 6.5 References…………………………………………………………………… 171 7. Conclusions and Future Perspectives 172 v ABBREVIATIONS General abbreviations Å Angstrom aq. aqueous bpy 2,2’-bipyridine CH3CN acetonitrile CHCl3 chloroform DCM dichloromethane DSC Differential Scanning Calorimetry DMSO dimethyl sulphoxide DNA 2’-deoxyribonucleic acid EA Elemental Analysis EtOH ethanol ICP-MS Inductively Coupled Plasma Mass Spectrometry ITC Isothermal Titration Calorimetry M molar Me methyl MeOH methanol MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide NH4PF6 ammonium hexafluorophosphate t-Bu4NCl tetrabutylammonium chloride µM micromolar µmol micromole mmol millimole vi mp. melting point m/z mass/charge nm nanometer P partition coefficient Ph phenyl phen 1,10-phenanthroline RNA ribonucleic acid Tm melting temperature (ct-DNA) terpy 2,2’:6’,2’-terpyridine Spectroscopic terms CD Circular Dichroism LD Linear Dichroism ICD Induced Circular Dichroism IR Infra-Red NMR Nuclear Magnetic Resonance UV-Vis Ultra-Violet - Visible ES Electrospray MS Mass Spectrometry NMR terms CDCl3 deuterated chloroform CD3CN deuterated acetonitrile COSY Correlated Spectroscopy D2O deuterium oxide vii δ chemical shift d doublet dd doublet of doublets MHz megahertz ppm parts per million q quartet s singlet t triplet UV-Vis terms MLCT Metal to Ligand Charge Transfer ε extinction coefficient hv light energy λ wavelength Fluorescence terms λex Wavelength of excitation λem Wavelength of emission Thermodynamic terms ΔCp heat capacity change ΔG free energy change ΔH enthalpy change ΔS entropy change ΔT temperature change viii K equilibrium binding constant R gas constant (8.314 J K-1 mol-1) DNA terms ct-DNA calf-thymus DNA ds-DNA double-stranded DNA ss-DNA single-stranded DNA A adenine C cytosine G guanine T thymine 3WJ DNA three-way junction Gel electrophoresis terms ϕ unwinding angle σ superhelicity rb coalescence point ix ABSTRACT The research work described in this thesis concerns metal-based
Recommended publications
  • Inventory Size (Ml Or G) 103220 Dimethyl Sulfate 77-78-1 500 Ml
    Inventory Bottle Size Number Name CAS# (mL or g) Room # Location 103220 Dimethyl sulfate 77-78-1 500 ml 3222 A-1 Benzonitrile 100-47-0 100ml 3222 A-1 Tin(IV)chloride 1.0 M in DCM 7676-78-8 100ml 3222 A-1 103713 Acetic Anhydride 108-24-7 500ml 3222 A2 103714 Sulfuric acid, fuming 9014-95-7 500g 3222 A2 103723 Phosphorus tribromide 7789-60-8 100g 3222 A2 103724 Trifluoroacetic acid 76-05-1 100g 3222 A2 101342 Succinyl chloride 543-20-4 3222 A2 100069 Chloroacetyl chloride 79-04-9 100ml 3222 A2 10002 Chloroacetyl chloride 79-04-9 100ml 3222 A2 101134 Acetyl chloride 75-36-5 500g 3222 A2 103721 Ethyl chlorooxoacetate 4755-77-5 100g 3222 A2 100423 Titanium(IV) chloride solution 7550-45-0 100ml 3222 A2 103877 Acetic Anhydride 108-24-7 1L 3222 A3 103874 Polyphosphoric acid 8017-16-1 1kg 3222 A3 103695 Chlorosulfonic acid 7790-94-5 100g 3222 A3 103694 Chlorosulfonic acid 7790-94-5 100g 3222 A3 103880 Methanesulfonic acid 75-75-2 500ml 3222 A3 103883 Oxalyl chloride 79-37-8 100ml 3222 A3 103889 Thiodiglycolic acid 123-93-3 500g 3222 A3 103888 Tetrafluoroboric acid 50% 16872-11-0 1L 3222 A3 103886 Tetrafluoroboric acid 50% 16872-11-0 1L 3222 A3 102969 sulfuric acid 7664-93-9 500 mL 2428 A7 102970 hydrochloric acid (37%) 7647-01-0 500 mL 2428 A7 102971 hydrochloric acid (37%) 7647-01-0 500 mL 2428 A7 102973 formic acid (88%) 64-18-6 500 mL 2428 A7 102974 hydrofloric acid (49%) 7664-39-3 500 mL 2428 A7 103320 Ammonium Hydroxide conc.
    [Show full text]
  • Asymmetric Cyclization Reactions Through an Enamine/Acid Cooperative Approach
    MIAMI UNIVERSITY The Graduate School Certificate for Approving the Dissertation We hereby approve the Dissertation of Yongming Deng Candidate for the Degree: Doctor of Philosophy Hong Wang, Advisor Michael Novak, Committee Chair Scott Hartley, Reader Shouzhong Zou, Reader Annette Bollmann, Graduate School Representative ABSTRACT ASYMMETRIC CYCLIZATION REACTIONS THROUGH AN ENAMINE/ACID COOPERATIVE APPROACH. SYNTHESIS OF UNSYMMETRICALLY FUNCTIONALIZED BENZOPORPHYRINS by Yongming Deng The combination of enamine catalysis with metal catalysis, aiming to achieve organic transformations that cannot be accessed by enamine catalysis or metal catalysis independently, promises huge potential. The major obstacle in the development of enamine/metal Lewis acid combining catalysis is the incompatibility of the catalysts. The goal of this research is to solve this long lasting challenge and develop powerful asymmetric catalysts. Chapter one will provide a brief introduction to asymmetric catalysis and combing catalysis of enamine catalysis with transition metal catalysis. In Chapter two, the first application of arylamines in enamine catalysis is presented. The incompatibility of enamine catalysts and metal Lewis acid is solved by applying arylamines/acids cooperative catalysis. Through combination with either a metal Lewis acid or a chiral phosphoric acid, arylamines successfully catalyzed the asymmetric aldol reaction of cyclohexanone with both isatin and enones. Additionally, a highly chemo- and enantioselective three-component aza-Diels-Alder reaction was developed by combining arylamines with metal Lewis acids. In Chapter three, we devise a new type of chiral Lewis-acid-assisted Lewis acid catalyst formed from a metal Lewis acid and a chiral metal phosphate (MLA/M[P]3-LLA). A highly chemo- and enantioselective three-component aza-Diels-Alder reaction of cylic ketones (5, 6, and 7 membered) was successfully achieved by in situ prepared MLA/M[P]3-LLA.
    [Show full text]
  • Biotin and Development of Some Useful Synthetic Methodologies
    SYNTHETIC STUDIES TOWARDS D(+)-BIOTIN AND DEVELOPMENT OF SOME USEFUL SYNTHETIC METHODOLOGIES THESIS SUBMITTED TO THE UNIVERSITY OF PUNE FOR THE DEGREE OF DOCTOR OF PHILOSOPHY (IN CHEMISTRY) BY Mr. CH. AMAR GOPAL DIVISION OF ORGANIC CHEMISTRY: TECHNOLOGY NATIONAL CHEMICAL LABORATORY PUNE – 411 008 (INDIA) APRIL 2001 Total Synthesis Of D(+)-Biotin: A Review Form-A CERTIFICATE Certified that the work incorporated in the thesis entitled “Synthetic Studies Towards D(+)-Biotin And Development Of Some Useful Synthetic Methodologies” by Mr CH. AMAR GOPAL was carried out by him under my supervision. Such material as has been obtained from other sources has been duly acknowledged in the thesis. April 2001 S. P. Chavan PUNE Research Guide 2 Total Synthesis Of D(+)-Biotin: A Review With Love To My Parents 3 Total Synthesis Of D(+)-Biotin: A Review Contents Page No. Acknowledgements i General Remarks iii Abbreviations iv Abstract v Chapter 1: Synthetic studies towards D(+)-biotin Section 1: Total synthesis of biotin: A review 1.1.1 Introduction 1 1.1.1a Structure determination 1 1.1.1b Biosynthesis 2 1.1.1c Biotin deficiency 2 1.1.2 Earlier approaches 6 1.1.3 References 27 Section 2: Reductive cleavage of C-S bond: Crucial intermediates for D(+)-biotin 1.2.1 Introduction 30 1.2.2 Retrosynthetic analysis 31 1.2.3 Results and discussion 31 1.2.4 Experimental 45 1.2.5 References 52 Section 3: 5,5 -Fused systems for D(+)-biotin systems 1.3.1 Introduction 53 1.3.2 Results and discussion 53 1.3.2a Ionic cyclization approach 57 1.3.2b Radical approach for
    [Show full text]
  • 31295017090514.Pdf (4.422Mb)
    LATENT FINGERPRINT AND TRACE EXPLOSIVES DETECTION BY PHOTOLUMINESCENCE AND TIME-RESOLVED IMAGING by KIMBERLY KAY BOULDIN, B.S., M.S. A DISSERTATION IN PHYSICS Submitted to the Graduate Faculty of Texas Tech University in Partial Fulfillment of the Requirements for the Degree of DOCTOR OF PHILOSOPHY Approved Chairperson of the Committee Accepted Dean of the Graduate School May, 2003 ACKNOWLEDGEMENTS I would like to thank my research advisor. Dr. Roland Menzel, and all of my committee members: Dr. Wallace Glab, Dr. Kelvin Cheng, and Dr. Edward Quitevis, for all of their guidance and support over the last several years. I want to thank Dr. Cheng for the phase-based lifetime measurements and the Graduate School at Texas Tech University for financial support in the summer of 1999. I would also like to thank Mr. Russell Murdock for his never-ending help and fiiendship. A special word of gratitude is extended to Menzel, Wally, RusselL, and the physics shop crew for all of the wisdom that was delivered over years of "technical discussions." I also thank my parents, Ted and Judy Bouldin, for all the love and encouragement they showered on me through my life. Mom and Dad, thank you both for encoiuraging me to set my goals high and teaching me to persevere until those goals were met. Finally, I would like to express how gratefiil I am to all of my family (with a special thanks to Finnan McClellan for his help with the figures), fiiends, and educators, both past and present. Without all of you, I would not be where I am today.
    [Show full text]
  • Studies on Lanthanide Shift Reagents A
    1 STUDIES ON LANTHANIDE SHIFT REAGENTS A thesis submitted for THE DEGREE OF DOCTOR OF PHILOSOPHY OF THE UNIVERSITY OF LONDON by George C. de VILLARDI de MONTLAUR Department of Chemistry Imperial College of Science and Technology London 1976 2 ABSTRACT Proton magnetic resonance studies of lanthanide shift reagents with olefin-transition metal complexes, monoamines and diamines as substrates are described. III Shift reagents for olefins are reported : Ln (fod)3 can induce substantial shifts in the nmr spectra of a variety of olefins when silver l-heptafluorobutyrate is used to com- plex the olefin. The preparation, properties and efficiency of such systems are described and various other transition metal-olefin complexes are investigated. Configurational aspects and exchange processes of III Ln (fod) complexes with secondary and tertiary monoamines 3 are analysed by means of dynamic nmr. Factors influencing the stability and the stoichiometry of these complexes and various processes such as nitrogen inversion and ligand ex- change are discussed. At low temperature, ring inversion can be slow on an III nmr time-scale for Ln (fod) -diamino chelates. Barriers 3 to ring inversion in substituted wthylenediamines and propane- diamines are obtained. Steric factors appear to play an im- portant role in the stability and kinetics of these bidentate species. 3 ACKNOWLEDGEMENTS I would like to express my gratitude to Dr. D. F. Evans for his constant help and long discussions during the course of this work. I would like to thank Professor G. Wilkinson for all the advice he gave me. My thanks are also due to the whole laboratory who contributed to render my stay in London extremely pleasant, to the Royal Society and C.N.R.S.
    [Show full text]